Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petta

Showing results (621-630 of 736) with videos related to

Pageof 74
Sort By:
Cancer Medicine|July 6, 2017
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver diseaseBenedetta Donati, Alessandro Pietrelli, Piero Pingitore, et al.
Nature Cancer|February 5, 2022
Zeb2 drives invasive and microbiota-dependent colon carcinomaKarolina Slowicka, Ioanna Petta, Gillian Blancke, et al.
Clinical and Molecular Hepatology|May 20, 2026
The Natural History and Individualized Prediction of Liver Stiffness-Based Fibrosis Risk in MASLDYu Shi, Ruoqi Zhou, Seung Up Kim, et al.
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.
Cell Death and Differentiation|December 2, 2020
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patientsMarion Picard, Satoru Yonekura, Karolina Slowicka, et al.
Journal of Hepatology|November 28, 2020
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Oveis Jamialahmadi, Serena Pelusi, et al.
Hepatology (Baltimore, Md.)|September 25, 2014
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular diseasePaola Dongiovanni, Salvatore Petta, Cristina Maglio, et al.
The Journal of Pathology|February 15, 2021
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2Deniz Kuscuoglu, Lisa Bewersdorf, Kathrin Wenzel, et al.
Science Translational Medicine|December 3, 2020
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosisOlivier Govaere, Simon Cockell, Dina Tiniakos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 24, 2023
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver diseaseRosaria M Pipitone, Francesco Malvestiti, Grazia Pennisi, et al.
Pageof 74

Showing results (621-630 of 736) with videos related to

Sort By:
Pageof 74
Cancer Medicine|July 6, 2017
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver diseaseBenedetta Donati, Alessandro Pietrelli, Piero Pingitore, et al.
Nature Cancer|February 5, 2022
Zeb2 drives invasive and microbiota-dependent colon carcinomaKarolina Slowicka, Ioanna Petta, Gillian Blancke, et al.
Clinical and Molecular Hepatology|May 20, 2026
The Natural History and Individualized Prediction of Liver Stiffness-Based Fibrosis Risk in MASLDYu Shi, Ruoqi Zhou, Seung Up Kim, et al.
Scientific Reports|July 5, 2017
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsBenedetta Donati, Paola Dongiovanni, Stefano Romeo, et al.
Cell Death and Differentiation|December 2, 2020
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patientsMarion Picard, Satoru Yonekura, Karolina Slowicka, et al.
Journal of Hepatology|November 28, 2020
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Oveis Jamialahmadi, Serena Pelusi, et al.
Hepatology (Baltimore, Md.)|September 25, 2014
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular diseasePaola Dongiovanni, Salvatore Petta, Cristina Maglio, et al.
The Journal of Pathology|February 15, 2021
Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2Deniz Kuscuoglu, Lisa Bewersdorf, Kathrin Wenzel, et al.
Science Translational Medicine|December 3, 2020
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosisOlivier Govaere, Simon Cockell, Dina Tiniakos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 24, 2023
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver diseaseRosaria M Pipitone, Francesco Malvestiti, Grazia Pennisi, et al.
Pageof 74